亚洲欧美不卡高清在线观看,伊人久久大香线蕉午夜av,亚洲综合色区在线观看,中文在线中文a,真正免费的毛片

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Eris Lifesciences Q2 net up 35 per cent at Rs 93.14 cr

expressbpdNovember 20, 2017

Tag: Eris , LifeSciences

Consolidated total income of the company also rose to Rs 255.68 crore

Drug firm Eris Lifesciences has reported a 34.51 per cent rise in its consolidated net profit to Rs 93.14 crore for the second quarter ended September 30. The company had posted a net profit of Rs 69.24 crore for the corresponding period of the previous fiscal, Eris Lifesciences said in a filing to BSE. Consolidated total income of the company also rose to Rs 255.68 crore for the quarter under consideration as against Rs 208.08 crore for the same period a year ago.

Previous:Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts to address impact of IV fluid shortag

Next:Strides Shasun divests India brand business to Eris Lifesciences for Rs 500 cr

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service